𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone

✍ Scribed by Cornelis G. ter Meulen; Peter J. H. Smak Gregoor; Willem Weimar; Luuk B. Hilbrands

Publisher
Springer
Year
2001
Tongue
English
Weight
49 KB
Volume
14
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
✍ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req

Conversion of liver transplant recipient
Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil
✍ Herrero, J. Ignacio ;Quiroga, Jorge ;Sangro, Bruno ;Girala, Marcos ;GΓ³mez-Manero πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 93 KB πŸ‘ 1 views

The management of liver transplant recipients with renal function impairment remains controversial because cyclosporine withdrawal from triple immunosuppression regimens may be followed by graft rejection. A nonnephrotoxic and powerful immunosuppressant such as mycophenolate mofetil (MMF) could allo

Mycophenolate mofetil, microemulsion cyc
Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients
✍ Renz, John F. ;Lightdale, Jennifer ;Mudge, Christine ;Bacchetti, Peter ;Watson, πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 85 KB

Triple immunosuppressive therapy using mycophenolate mofetil (MMF), microemulsion cyclosporine (me-CsA), and prednisone offers the potential for potent immunosuppression without intravenous drug therapy or anti-T-cell antibody induction therapy. This report describes the application of an immunosupp